Life Science Company News

Reset
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Apellis Pharmaceuticals, Inc.

Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Tilray Inc.

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Kamada Ltd.

Opthea Announces Upcoming Presentations at the Retina World Congress 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Opthea Limited

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Ocular Therapeutix, Inc.

Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Zevra Therapeutics, Inc.

Repligen Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Repligen Corporation

VitalHub Announces Strategic Leadership Appointments to Drive Continued Growth and Operational Excellence

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  VitalHub Corp

Altimmune to Participate at Two Upcoming Conferences

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Altimmune, Inc. | Analytica Ltd

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Minerva Neurosciences Inc.

Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Atsena Therapeutics, Inc.

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  MDxHealth

Aeterna Zentaris Announces Effective Date of Share Consolidation

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  AEterna Zentaris Inc.

Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Catalyst Pharmaceuticals, Inc.

4DMT Announces Presentations at ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  4D Molecular Therapeutics, Inc.

Inovalon Earns 2024 Great Place To Work® Certification™ For Second Consecutive Year

Read more ››
By: GlobeNewswire - 01 May 2024

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Corbus Pharmaceuticals Holdings, Inc.

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Benitec Biopharma Inc.

ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  ImmuneSensor Therapeutics, Inc

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Denali Therapeutics Inc.
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »